drugset / Trial / NCT02990910

Individualized Analgesia After Adenotonsillectomy

NCT02990910

RandomizedParallel-groupQuadruple-blindPrevention

Summary

A high incidence of respiratory morbidity after adenotonsillectomy is reported in children with obstructive sleep apnea syndrome (OSAS). So we designed a prospective, double-blind, randomized controlled study to determine the effects of individualized opioid analgesia compared with conventional opioid analgesia on respiratory morbidity after adenotonsillectomy in Children with OSAS.

Timeline

Start
2016-11
Primary completion
2017-02
Completion
2017-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified 10 ug/kg
Subject Morphine Other / unclassified 50 ug/kg

Indications

No indication recorded.